ReviewBMJ open gastroenterology2021
Recurrent myocarditis in a patient with active ulcerative colitis: a case report and review of the literature.
Review in BMJ open gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 20 citations in OpenAlex.
- Recurrent Pleuropericarditis Associated with Mesalazine Therapy Masked by Steroid Use.European journal of case reports in internal medicine · 2026Article
- Article
- Ulcerative Colitis with Acute Pericarditis after Dose Escalation of Mesalazine.Internal medicine (Tokyo, Japan) · 2025Article
- Cardiac Arrest Due to Lymphocytic Colitis.Cureus · 2025Article
- Review
- Mesalazine-induced myocarditis in a patient with ulcerative colitis: a case report.European heart journal. Case reports · 2024Article
- Article
- Mesalazine-induced myopericarditis: a case series.European heart journal. Case reports · 2023Article
- Cardiovascular manifestations of inflammatory bowel diseases and the underlying pathogenic mechanisms.American journal of physiology. Regulatory, integrative and comparative physiology · 2023Review
- Myocarditis With Cardiogenic Shock in a Young Female With Severe Ulcerative Colitis Flare.Journal of community hospital internal medicine perspectives · 2023Article
- Myocarditis as an extraintestinal manifestation of ulcerative colitis: A case report and review of the literature.World journal of clinical cases · 2022Article
- [Acute myocarditis after a third dose of the BNT162b2 COVID-19 vaccine].Revista espanola de cardiologia · 2022Article
- Acute myocarditis after a third dose of the BNT162b2 COVID-19 vaccine.Revista espanola de cardiologia (English ed.) · 2022Article
- Analysis of clinical characteristics of mesalazine-induced cardiotoxicity.Frontiers in pharmacology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory bowel diseases such as ulcerative colitis (UC) may be complicated by several extraintestinal manifestations. These involve joints, skin, eyes and less commonly lungs and heart. Myocarditis may result from the toxic effect of drugs (ie, mesalazine) commonly used for the treatment of UC or due to infections (eg, Coxsackieviruses, enteroviruses, adenovirus). Here, we report a case of a 26-year old man affected by UC and complicated by two episodes of myocarditis. Both episodes occurred during two severe exacerbations of UC. However, in both cases the aetiology of myocarditis remains uncertain being ascribable to extraintestinal manifestation, drug toxicity or both.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.